Document detail
ID

oai:pubmedcentral.nih.gov:1082...

Topic
Systematic Review
Author
Dlima, Jessica Kitisarn, Rooj Lim, Han Thijs, Vincent
Langue
en
Editor

BMJ Publishing Group

Category

BMJ Neurology Open

Year

2024

listing date

6/11/2024

Keywords
review af stroke relationship
Metrics

Abstract

IMPORTANCE: Atrial fibrillation (AF) is an established risk factor for ischaemic stroke.

The introduction of continuous cardiac rhythm monitoring devices has enabled detection of brief and asymptomatic episodes of AF.

OBSERVATIONS: The search yielded 727 studies, 11 of which met the inclusion criteria.

Four studies suggested a strong temporal association between episodes of AF and stroke, while seven indicated a weak relationship.

The conflicting nature of the studies may be attributed to inconsistencies in ischaemic stroke verification (n=5/11), event rate and power (n=6/11) and lack of controlling for anticoagulation (n=10/11), mitigating the relationship between AF episodes and stroke.

CONCLUSIONS AND RELEVANCE: The temporal relationship between AF and stroke still remains unclear due to varying study methodology, lack of control for anticoagulation and inconsistent stroke subtyping.

Our review identifies limitations to the current literature and makes recommendations for future studies assessing the temporal relationship between AF episodes and cardioembolic stroke.

Dlima, Jessica,Kitisarn, Rooj,Lim, Han,Thijs, Vincent, 2024, Is there a temporal relationship between atrial fibrillation and stroke? A review, BMJ Publishing Group

Document

Open Open

Share

Source

Articles recommended by ES/IODE AI

MELAS: Phenotype Classification into Classic-versus-Atypical Presentations
presentations mitochondrial strokelike patients variability phenotype clinical melas
Protocol for the promoting resilience in stress management (PRISM) intervention: a multi-site randomized controlled trial for adolescents and young adults with advanced cancer
cancer quality of life anxiety depression hope coping skills communication intervention randomized ayas outcomes resilience care trial cancer prism-ac advanced